IRCT2014121213090N2已完成未知
Efficiency of carvedilol in the protection of Anthracycline-induced cardiomyophy in cancer patients undergoing chemotheraphy compared with control group
Vice Chancellor for research of Mazandaran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Cancer patients; 18-70 years old; newly diagnosed; candidate for antracyclin therapy. Exclusion criteria: history of myocardial infarction; coronary artery disease; LVEF<50%; significant valvular heart disease; history of congestive heart failure; sinus bradycardia, complete heart block, systolic blood pressure less than 90 mmHg.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Assessment the effect of Carvedilol in preventing Heart failure in breast cancer patients.IRCT2017042433619N1Vice chancellor for research of Baqiyatallah University of Medical Sciences50
已完成
3 期
Evaluation of Early Disease in Familial Dilated CardiomyopathyFamilial dilated cardiomyopathyCardiovascular - Other cardiovascular diseasesACTRN12605000204640St Vincent's Hospital, Darlinghurst64
已完成
2 期
Study the preventive effect of Carvedilol therapy against Adriamycin-induced acute cardiotoxicity in breast cancer patients by measurement of myocardial deformation indexCongestive heart failureCondition 1: breast cancer. Condition 2: heart failure.Breast, unspecifiedIRCT2013093012924N1Vice chancellor for research, Mashhad University of Medical Sciences70
招募中
3 期
Effect of Carvedilol on Reducing Transtosomab Cardiac ComplicationsIRCT20190628044046N1Tehran University of Medical Sciences60
招募中
3 期
Evaluation of the effect of carvedilol in patients with gastrointestinal cancerGastrointestinal cancers (Esophageal cancer, Gastric cancer, Pancreatic cancer, Colon cancer).Malignant neoplasm of stomachIRCT20200907048646N1Ardabil University of Medical Sciences60